{"nct_id":"NCT02169180","title":"Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Relapsed or Refractory Mantle Cell Lymphoma","status":"COMPLETED","status_verified_date":"2017-01","start_date":"2014-08","start_date_type":null,"primary_completion_date":"2016-11","primary_completion_date_type":"ACTUAL","completion_date":"2016-12","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["JNJ"]}